Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Buckland

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biotechnology and Bioengineering|March 13, 2012
Vaccine process technologyJessica O Josefsberg, Barry Buckland
Vaccine|March 4, 2014
Vaccine Technology IV: an ECI Conference held in Albufeira, Portugal from May 20 to 24, 2012David B Weiner, Barry Buckland
Biotechnology and Bioengineering|April 4, 2003
Toward consistent and productive complex media for industrial fermentations: studies on yeast extract for a recombinant yeast fermentation processJinyou Zhang, Jayanthi Reddy, Barry Buckland, et al.
Current Opinion in Chemical Biology|March 21, 2016
Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccineJanine T Bryan, Barry Buckland, Jennifer Hammond, et al.
Biotechnology and Bioengineering|May 7, 2024
Vaccine process technology-A decade of progressBarry Buckland, Gautam Sanyal, Todd Ranheim, et al.
Vaccine|August 19, 2014
Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing processBarry Buckland, Robert Boulanger, Mireli Fino, et al.
Journal of Pharmaceutical Sciences|January 16, 2014
Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storageJohn M Hickey, Kathleen M Holtz, Prakash Manikwar, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biotechnology and Bioengineering|March 13, 2012
Vaccine process technologyJessica O Josefsberg, Barry Buckland
Vaccine|March 4, 2014
Vaccine Technology IV: an ECI Conference held in Albufeira, Portugal from May 20 to 24, 2012David B Weiner, Barry Buckland
Biotechnology and Bioengineering|April 4, 2003
Toward consistent and productive complex media for industrial fermentations: studies on yeast extract for a recombinant yeast fermentation processJinyou Zhang, Jayanthi Reddy, Barry Buckland, et al.
Current Opinion in Chemical Biology|March 21, 2016
Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccineJanine T Bryan, Barry Buckland, Jennifer Hammond, et al.
Biotechnology and Bioengineering|May 7, 2024
Vaccine process technology-A decade of progressBarry Buckland, Gautam Sanyal, Todd Ranheim, et al.
Vaccine|August 19, 2014
Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing processBarry Buckland, Robert Boulanger, Mireli Fino, et al.
Journal of Pharmaceutical Sciences|January 16, 2014
Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storageJohn M Hickey, Kathleen M Holtz, Prakash Manikwar, et al.
Pageof 1